In this issue of Interventional Cardiology Clinics, guest editor Dr. Nadia Sutton brings her considerable expertise to the topic of Cardiovascular Procedures in Women. Top experts in the field discuss the clinical approach to angina in women; revascularization strategies in women: do women benefit as much as men?; acute coronary syndrome management in women; dual antiplatelet and anticoagulation regimens for women undergoing percutaneous coronary intervention; and much more. - Contains 14 relevant, practice-oriented topics including strategies to improve the clinical outcomes of women with cardiogenic shock; considerations in the care of transgender and gender diverse patients requiring cardiac catheterization; considerations for women with congenital heart disease undergoing percutaneous cardiovascular procedures; and more. - Provides in-depth clinical reviews on cardiovascular procedures in women, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Interventional Cardiology Clinics, guest editor Dr. Nadia Sutton brings her considerable expertise to the topic of Cardiovascular Procedures in Women. Top experts in the field discuss the clinical approach to angina in women; revascularization strategies in women: do women benefit as much as men?; acute coronary syndrome management in women; dual antiplatelet and anticoagulation regimens for women undergoing percutaneous coronary intervention; and much more. Contains 14 relevant, practice-oriented topics including strategies to improve the clinical outcomes of women with cardiogenic shock; considerations in the care of transgender and gender diverse patients requiring cardiac catheterization; considerations for women with congenital heart disease undergoing percutaneous cardiovascular procedures; and more. Provides in-depth clinical reviews on cardiovascular procedures in women, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Heart disease is the leading cause of death among US women over the age of 65, resulting in more deaths than all forms of cancer combined. Women are less likely to survive heart attacks than are men, possibly because symptoms in women may differ and may be less recognizable. In addition, women consistently tend to have worse clinical outcomes in percutaneous coronary interventions than do men. For these reasons, an issue on percutaneous interventions in women is timely.

This issue of Interventional Cardiology Clinics will explore Updates in Percutaneous Coronary Intervention. Curated by the series Editor-in-Chief, Dr. Matthew J. Price, this issue will cover topics and advances in the field that are relevant for practicing clinicians. This issue is one of four selected each year by Dr. Price. The volume will include articles on: Current Concepts in Intraprocedural Pharmacology During PCI; Periprocedural Myocardial Infarction in Contemporary Practice; Newer Generation Metallic Stents: Design, Performance Characteristics, and Outcomes; Distal Transradial Access for Coronary Angiography and Intervention; Clinical Outcomes Data for iFR-guided PCI; Culprit-only or Complete Revascularization During STEMI in Patients with and Without Shock; Technical Approaches to Left Main Coronary Intervention: Contemporary Best Practices; Robotic Assisted Percutaneous Coronary Intervention; Orbital Atherectomy: A Comprehensive Review; and Percutaneous revascularization of spontaneous coronary artery dissection, among others.

Heart disease is the leading cause of death among US women over the age of 65, resulting in more deaths than all forms of cancer combined. Women are less likely to survive heart attacks than are men, possibly because symptoms in women may differ and may be less recognizable. In addition, women consistently tend to have worse clinical outcomes in percutaneous coronary interventions than do men. For these reasons, an issue on percutaneous interventions in women is timely.

This issue of Interventional Cardiology Clinics, guest edited by Dr. Herbert Aronow, will discuss Updates in Peripheral Vascular Intervention. This issue is one of four selected each year by the series Editor-in-Chief, Dr. Matthew Price. Topics discussed in this issue will include: Vascular access, alternative vascular access and vascular closure/hemostasis, Wires, catheters and sheaths, balloons and stents, Plaque modification (eg., atherectomy, lithoplasty) devices, Embolic protection, Renal and mesenteric artery intervention, Iliac intervention, Fem-pop intervention, Below-the-knee intervention, Acute limb ischemia intervention, Catheter-directed therapy for pulmonary embolism, Intervention for liofemoral DVT and May Thurner, Venous ablation, among others.

This book describes a wide range of interventional procedures currently employed in the treatment of cardiac diseases in women with the aim of enabling not only interventional cardiologists but also cardiologists and cardiac surgeons to refine their approach to female patients and thus improve outcomes. The book reflects the increasing awareness of gender differences with regard to coronary artery disease and structural valve heart disease. Examples include myocardial infarction, which carries a worse prognosis in women in part because they suffer from this disease mostly in the 7th decade of life, present more frequently with hemodynamic instability and later from symptom onset, and have fragile, small and tortuous coronary arteries that are more technically demanding in the context of primary percutaneous coronary intervention. Another example is symptomatic aortic stenosis, which carries a better prognosis in women who undergo trans-catheter aortic valve implantation partially due to a better annulus-prosthesis match, which leads to less residual paravalvular regurgitation, better left ventricular function and lower aggregation of comorbidities. Further, in women left ventricular response to aortic stenosis is typified by muscle hypertrophy with a small ventricular cavity. These differences are reflected in the clinical manifestations and their impact on diagnosis, treatment, and choice of tools and devices for use in interventional procedures. By explaining the at times subtle variances in disease and treatment techniques for female and male patients, this book will help practitioners select the most appropriate procedures and materials in a range of settings.

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

In ST segment elevation myocardial infarction (STEMI), the coronary artery is completely blocked by a blood clot. It is the most serious type of heart attack. The best treatment for STEMI patients is to have the blocked artery opened by balloon inflation within 90 minutes of arriving at a hospital. The 90-minute window is called “door-to-balloon time. The shorter the door-to-balloon time, the greater the chance of survival. Treatment of this life-threatening illness is reviewed in this issue.

This issue of Interventional Cardiology Clinics, guest edited by Dr. Herbert Aronow, will discuss Updates in Peripheral Vascular Intervention. This issue is one of four selected each year by the series Editor-in-Chief, Dr. Matthew Price. Topics discussed in this issue will include: Vascular access, alternative vascular access and vascular closure/hemostasis, Wires, catheters and sheaths, balloons and stents, Plaque modification (eg., atherectomy, lithoplasty) devices, Embolic protection, Renal and mesenteric artery intervention, Iliac intervention, Fem-pop intervention, Below-the-knee intervention, Acute limb ischemia intervention, Catheter-directed therapy for pulmonary embolism, Intervention for liofemoral DVT and May Thurner, Venous ablation, among others.